1. Home
  2. VRAR vs CLDI Comparison

VRAR vs CLDI Comparison

Compare VRAR & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Glimpse Group Inc.

VRAR

The Glimpse Group Inc.

HOLD

Current Price

$1.03

Market Cap

21.9M

Sector

Technology

ML Signal

HOLD

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

HOLD

Current Price

$1.49

Market Cap

9.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAR
CLDI
Founded
2016
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.9M
9.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
VRAR
CLDI
Price
$1.03
$1.49
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$2.62
N/A
AVG Volume (30 Days)
101.7K
81.8K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,488,209.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$72.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.60
N/A
52 Week Low
$0.96
$1.10
52 Week High
$7.00
$23.16

Technical Indicators

Market Signals
Indicator
VRAR
CLDI
Relative Strength Index (RSI) 38.07 47.63
Support Level $1.03 $1.41
Resistance Level $1.16 $1.54
Average True Range (ATR) 0.08 0.08
MACD 0.01 0.01
Stochastic Oscillator 0.00 59.09

Price Performance

Historical Comparison
VRAR
CLDI

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

Share on Social Networks: